Literature DB >> 3532970

Fetal allograft survival in immunocompetent recipients is age dependent and organ specific.

R P Foglia, J DiPreta, M B Statter, P K Donahoe.   

Abstract

This study explores whether fetal allograft survival is age dependent and organ specific. Fetal rat tissue (renal, gonadal, hepatic) from the third trimester of gestation (days 15-21) was transplanted into 306 outbred adult rats for 10-30 days. Grafts were studied by morphometric and histologic analysis. Ten days after implantation, renal tissue (N = 75) from late gestation (days 19-21) showed no increase in size. In contrast, 17-day fetal grafts (N = 20) grew 6.8 +/- 3.4 times,* while 15-day fetal grafts (N = 28) grew 17.5 +/- 6.1* times. (The symbol "*" indicates p less than 0.05, compared to original size). Twenty days after implantation, these 15-day fetal grafts (N = 20) grew 48.8 +/- 17.7* times. Ten days after grafting, the younger fetal tissue showed excellent maturation of renal elements and no sign of rejection; older fetal grafts had poor renal architecture and a dense lymphocytic infiltrate. The 15-day fetal gonadal tissue (N = 18) showed a moderate 10.6 +/- 3.2* increase in size while the 15-day hepatic grafts (N = 16) were regularly rejected within 10 days. Selected fetal allografts from early in the third trimester can not only survive but can grow and mature in an immunocompetent recipient. This fetal graft growth appears to be both age dependent and organ specific. The use of fetal organs may broaden the potential pool for transplantation. However, further studies are needed to define the ontogeny of graft acceptance.

Entities:  

Mesh:

Year:  1986        PMID: 3532970      PMCID: PMC1251308          DOI: 10.1097/00000658-198610000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  The immunologic problem of pregnancy.

Authors:  R L SIMMONS; P S RUSSELL
Journal:  Am J Obstet Gynecol       Date:  1963-03-01       Impact factor: 8.661

2.  Control of experimental diabetes mellitus in rats by transplantation of fetal pancreases.

Authors:  J Brown; I G Molnar; W Clark; Y Mullen
Journal:  Science       Date:  1974-06-28       Impact factor: 47.728

3.  Evidence for the time of appearance of H-2 antigens in mouse development.

Authors:  H Patthey; M Edidin
Journal:  Transplantation       Date:  1973-02       Impact factor: 4.939

4.  Transplantation of fetal intestine: survival and function in a subcutaneous location in adult animals.

Authors:  S B Leapman; A A Deutsch; R J Grand; J Folkman
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

Review 5.  Regulation of the immune response by the major histocompatibility system.

Authors:  H O McDevitt
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

6.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

7.  Expression of serologically detectable H-2 antigens on mid-gestation mouse embryonic tissues.

Authors:  K J Kirkwood; W D Billington
Journal:  J Embryol Exp Morphol       Date:  1981-02

8.  Cell-free synthesis and membrane insertion of mouse H-2Dd histocompatibility antigen and beta 2-microglobulin.

Authors:  B Dobberstein; H Garoff; G Warren; P J Robinson
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

9.  UCLA Conference. Pancreas transplantation for diabetes mellitus.

Authors: 
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

10.  Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assay.

Authors:  A E Bogden; W R Cobb; D J Lepage; P M Haskell; T A Gulkin; A Ward; D E Kelton; H J Esber
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

View more
  17 in total

1.  Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows.

Authors:  Smadar Eventov-Friedman; Helena Katchman; Elias Shezen; Anna Aronovich; Dalit Tchorsh; Benjamin Dekel; Enrique Freud; Yair Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

2.  Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation.

Authors:  Anna Aronovich; Dalit Tchorsh; Helena Katchman; Smadar Eventov-Friedman; Elias Shezen; Uri Martinowitz; Bruce R Blazar; Sivan Cohen; Orna Tal; Yair Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

Review 3.  Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Tissue Eng Part B Rev       Date:  2019-11-27       Impact factor: 6.389

4.  Organogenesis of kidney and endocrine pancreas: the window opens.

Authors:  Marc R Hammerman
Journal:  Organogenesis       Date:  2007-10       Impact factor: 2.500

Review 5.  Transplantation of renal primordia: renal organogenesis.

Authors:  Marc R Hammerman
Journal:  Pediatr Nephrol       Date:  2007-08-01       Impact factor: 3.714

6.  Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model.

Authors:  Gil Hecht; Smadar Eventov-Friedman; Chava Rosen; Elias Shezen; Dalit Tchorsh; Anna Aronovich; Enrique Freud; Hana Golan; Ronit El-Hasid; Helena Katchman; Bernhard J Hering; Amnon Zung; Zipi Kra-Oz; Pninit Shaked-Mishan; Alex Yusim; Alex Shtabsky; Pavel Idelevitch; Ana Tobar; Alon Harmelin; Esther Bachar-Lustig; Yair Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

7.  Hepatic reconstruction from fetal porcine liver cells using a radial flow bioreactor.

Authors:  Yuji Ishii; Ryota Saito; Hideki Marushima; Ryusuke Ito; Taro Sakamoto; Katsuhiko Yanaga
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

8.  B-cell depletion improves islet allograft survival with anti-CD45RB.

Authors:  Kang Mi Lee; Heidi Yeh; Gaoping Zhao; Lingling Wei; Matthew O'Connor; Ryan T Stott; Julie Soohoo; Kyri Dunussi; Paolo Fiorina; Shaoping Deng; James F Markmann; James I Kim
Journal:  Cell Transplant       Date:  2012-11-27       Impact factor: 4.064

9.  Fetal pancreas transplants are dependent on prolactin for their development and prevent type 1 diabetes in syngeneic but not allogeneic mice.

Authors:  Gwladys Fourcade; Bruno M Colombo; Sylvie Grégoire; Audrey Baeyens; Latif Rachdi; Fanny Guez; Vincent Goffin; Raphael Scharfmann; Benoît L Salomon
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461

10.  Fetal pancreas as a source for islet transplantation: sweet promise and current challenges.

Authors:  Smadar Eventov-Friedman; Yair Reisner
Journal:  Diabetes       Date:  2013-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.